Makan Delrahim’s confirmation as head of the U.S. Department of Justice’s Antitrust Division comes with several major mergers up for review and politicians clamoring for stepped-up enforcement, and the decisions made on these deals could shed light on the direction and posture of the division going forward. Here, Law360 takes a look at some of the transactions waiting on Delrahim's desk.
The Boeing Company will pay $615 million to settle U.S. Department of Justice probes into allegations that Boeing illegally obtained and used competitors' information to win contracts worth billions of dollars from NASA and the Air Force.
The Washington utility company that helped uncover an Enron Corp. conspiracy to manipulate energy markets will not have to pay Enron a $120 million contract termination fee, federal regulators have determined.
Echoing an earlier vote by the U.S. House of Representatives, a Senate committee rejected an amendment to block phone and cable companies from restricting access to their high-speed Internet networks by giving preferential treatment to Internet sites.
Brand-name drug manufacturers, facing potentially billions of dollars in losses when their patent protection on drugs expires, are attempting to protect their market shares by slashing prices to undercut the generic competition--a move that has some accusing the pharmaceutical companies of predatory pricing.
The first class action was filed against BP Products North America just one day after a former trader at the U.S. unit pled guilty to partaking in a scheme to manipulate the propane market.
The European Commission proposed new regulations Thursday to promote competition in the telecommunications industry, inciting anxiety among telecom giants less than a week after E.C. director Neelie Kroes warned of a possible probe of the $338 billion industry.
Marking a turn in the road for Mexico’s antitrust watchdog, the country’s revamped competition guidelines became law this week after months of deliberation by lawmakers and lobbyists.
A Chinese anti-monopoly law long sought by U.S. and European businesses failed to pass China’s parliament Thursday, placing it back into a seemingly endless limbo that began nearly 20 years ago when it was first introduced.
In the wake of a new study lauding the competitive effects of authorized generics, the Generic Pharmaceutical Association has issued a blistering statement calling into question the reliability of the report.
Rallying against lawmakers, the U.S. Department of Justice’s Antitrust Division and the Federal Trade Commission this week lashed out against proposed legislation that seeks to curb non-lawyers from competing with licensed attorneys in the real estate industry in New York state, saying the move is not in the best interest of consumers.
The European Commission’s antitrust commissioner has confirmed that harsh new penalties are on the horizon for companies that violate the continent’s competition laws, and provided details about how new procedural changes will make that happen.
In a decision that could affect future white collar cases, a district court judge in Manhattan ruled Tuesday that the government violated the constitutional rights of former KPMG LLP partners by pressuring the firm to not pay their legal fees.
A federal court in Washington, D.C. will decide whether or not to approve the settlements that paved the way for the AT&T/SBC and MCI/Verizon mergers in a hearing scheduled for next month.
The Senate Judiciary Committee plans to dive into a heated debate over credit card interchange rates and potential antitrust concerns at an upcoming hearing.
Four top Senate judiciary committee members are taking matters into their own hands and introducing legislation to prohibit brand-name drug makers from paying rivals to keep generic drugs off the market.
Two U.S. vehicle auctioneers have resolved a dispute over patent infringement allegations fueled by an online auction system and alleged antitrust violations in the vehicle auction market.
A Swiss competition administration has begun an investigation into three major drug producers that authorities believe may be fixing prices for impotence drugs.
In the latest development in a long-running battle that has already cost Microsoft Corp. €497 million in fines, European antitrust authorities are expected to levy yet another staggering fine against the software giant, according to published reports.
After weeks of wrangling, Adelphia Communications Corp. has finally received permission to sell its assets to Time Warner Corp. and Comcast Corp.
As McClatchy Co. and Knight-Ridder Inc. inch towards their multi-billion dollar merger, the U.S. Department of Justice said in a civil antitrust lawsuit filed this week that it will require the merged publishing company to divest the St. Paul Pioneer Press in order to preserve local competition.